bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2410
-0.0209 (-7.98%)
Mar 31, 2025, 1:24 PM EDT - Market open
bioAffinity Technologies Stock Forecast
BIAF's stock price has decreased by -87.16% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for bioAffinity Technologies stock has a target of 6.00, which predicts an increase of 2,389.63% from the current stock price of 0.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 23, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for bioAffinity Technologies is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +2,389.63% | Jul 23, 2024 |
Financial Forecast
Revenue This Year
9.76M
from 2.53M
Increased by 285.51%
Revenue Next Year
11.72M
from 9.76M
Increased by 20.05%
EPS This Year
-0.84
from -0.91
EPS Next Year
-0.67
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.1M | 12.1M | 14.5M |
| Avg | 9.8M | 11.7M | 14.1M |
| Low | 9.4M | 11.3M | 13.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 296.9% | 23.6% | 23.5% |
| Avg | 285.5% | 20.0% | 20.0% |
| Low | 270.4% | 15.3% | 15.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.72 | -0.69 | -0.48 |
| Avg | -0.84 | -0.67 | -0.47 |
| Low | -0.93 | -0.65 | -0.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.